Skyline gets green light for AMD gene therapy trial

Skyline gets green light for AMD gene therapy trial

By Longevity technology Gene therapy company Skyline Therapeutics has received Investigational New Drug application clearance from the US FDA for its gene therapy candidate for the treatment of neovascular age-related macular degeneration (nAMD). The company is now...